Global Multiplex Antigen Microarray Market Growth (Status and Outlook) 2025-2031

The global Multiplex Antigen Microarray market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years.

In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years.

From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis.

Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years.

Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

ReportPrime' newest research report, the “Multiplex Antigen Microarray Industry Forecast” looks at past sales and reviews total world Multiplex Antigen Microarray sales in 2024, providing a comprehensive analysis by region and market sector of projected Multiplex Antigen Microarray sales for 2025 through 2031. With Multiplex Antigen Microarray sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multiplex Antigen Microarray industry.

This Insight Report provides a comprehensive analysis of the global Multiplex Antigen Microarray landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyses the strategies of leading global companies with a focus on Multiplex Antigen Microarray portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multiplex Antigen Microarray market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multiplex Antigen Microarray and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

1. Segmentation by Type:

• Autoantibody Detection
• Biomarker Profiling

1. Segmentation by Application:

• Drug Discovery
• Therapeutics
• Others

1. Market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

1. Company's coverage:

• Illumina
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Agilent Technologies
• PerkinElmer
• Intuitive Biosciences
• GE Healthcare
• BioChain
• Sengenics
• Applied Microarrays
• US Biomax

1. Key Questions Addressed in this Report: